在帕金森病中将热冲击蛋白70和帕金森连接起来
Zhongting Zhao1, Zheng Li2, Fangning Du1
1Key Laboratory of Flexible Electronics (KLoFE) & Institute of Advanced Materials (IAM), School of Flexible Electronics (Future Technologies), Nanjing Tech University, Nanjing, 211816, People's Republic of China.
Molecular neurobiology
|August 1, 2023
概括
热冲击蛋白70 (Hsp70) 和帕金斯在帕金森病 (PD) 发病过程中至关重要. 这些蛋白质的失调及其相互作用有助于神经退行,为PD提供潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,影响全球数百万人,主要以多巴胺基神经元的损失为特征.
- 蛋白质错误折叠,聚合和降解受损被认为是PD病变发生的中心机制.
- 热冲击蛋白70 (Hsp70) 和帕金是细胞蛋白质质量控制和降解途径的关键参与者.
研究的目的:
- 审查热冲击蛋白70 (Hsp70) 和帕金斯在帕金森病 (PD) 发病过程中的作用.
- 在PD的背景下阐明Hsp70和帕金的相互作用.
- 探索针对Hsp70和帕金因通路治疗PD的治疗潜力.
主要方法:
- 文献综述侧重于最近关于Hsp70,帕金森和帕金森病的研究.
- 对涉及PD中蛋白质降解途径的分子机制的分析.
- 关于神经退行过程中Hsp70和帕金的相互作用信息的综合.
主要成果:
- Hsp70和帕金因的失调对PD的发展和进展作出了重大贡献.
- Hsp70和帕金表现出关键的相互作用,影响了涉及PD的错误折叠和聚合蛋白质的清除.
- 这些蛋白质的异常功能加剧了 substantia nigra pars compacta 中的神经元损伤.
结论:
- Hsp70和帕金是PD病变的重要分子参与者,它们的失调导致神经退行.
- Hsp70和帕金的相互作用为了解PD和潜在治疗PD提供了一个有希望的途径.
- 准Hsp70和帕金因通路对缓解PD进展和神经毒性具有治疗前景.
相关概念视频
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Overview
598
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
598
Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K
Parkinson's Disease: Treatment
299
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
299
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


